TAMSULOSIN retard Zentiva caps ret 0.4 mg 30 pce

7680672540023 CH-67254 G04CA02 05.99.0.

Active substances:

TAMSULOSIN retard Zentiva caps ret 0.4 mg 30 pce
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
6725401
CPT
-
Packaging group
30
Unit
Kapsel(n)
Composition
tamsulosini hydrochloridum 0.4 mg corresp. tamsulosinum 0.367 mg, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, natrii laurilsulfas corresp. natrium 0.0264 mg, cellulosum microcristallinum, dibutylis sebacas, polysorbatum 80, silica colloidalis hydrica, calcii stearas, Kapselhülle: gelatina, E 132, E 172 (nigrum), E 172 (rubrum), E 172 (flavum), E 171, pro capsula.

Articles (1)

Tamsulosin retard Zentiva 0.4 mg, Hartkapseln, retardiert
Kapseln
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
03/07/2026
Patient information leaflet
Français
03/07/2026
Patient information leaflet
Italien
03/07/2026
Professional SmPC
Allemand
02/07/2026
Professional SmPC
Français
02/07/2026
Professional SmPC
Italien
02/07/2026

Detailed composition

Substance Quantity Type Category
tamsulosini hydrochloridum
0.4 MG Substance Wirkstoff (Principe actif)
tamsulosinum
0.367 MG Substance WIIS
acidi methacrylici et ethylis acrylatis polymerisatum 1:1
- Substance HNIDK
natrii laurilsulfas
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
natrium
0.0264 MG Substance HBESI
cellulosum microcristallinum
- Substance HNIDK
dibutylis sebacas
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
silica colloidalis hydrica
- Substance HNIDK
calcii stearas
- Substance HNIDK
gelatina
- Substance HNIDK
E 132
- Substance FIMDK
E 172 (nigrum)
- Substance FTODK
E 172 (rubrum)
- Substance FTODK
E 172 (flavum)
- Substance FTODK
E 171
- Substance FNIDK

Reimbursement information

Public price
CHF 27.45
Specialties list
Yes
Generic
Yes
SL addition date: 01/04/2020

Authorization holder

Helvepharm AG

8500 Frauenfeld

Authorization information

Swissmedic authorization number
67254
Drug name
Tamsulosin retard Zentiva, Hartkapseln, retardiert
Galenic form
RETH
ATC Code
G04CA02
Authorization status
Z
Dispensation category
B
First authorization
19/06/2019
Authorization expiration date
31/12/9999
IT number
05.99.0.
Domain
Human medicine
Field of application
benigne Prostatahyperplasie

Packaging details

Description (FR)
TAMSULOSIN retard Zentiva caps ret 0.4 mg 30 pce
Description (DE)
TAMSULOSIN retard Zentiva Ret Kaps 0.4 mg 30 Stk
Market launch
19/06/2019
Narcotic (BTM)
No

Other packaging sizes

TAMSULOSIN retard Zentiva caps ret 0.4 mg 10 pce
10 KAP
View
TAMSULOSIN retard Zentiva caps ret 0.4 mg 100 pce
100 KAP
View
Buy us a coffee Explore the data